Pre Diagnostics is the first diagnostics company to focus on intracellular measurements of disease-specific biomarkers inside the blood cells. We extract disease-relevant information from biomarkers located inside specific blood cells called monocytes to provide actionable results for patient and practitioner.

Pre Diagnostic’s first test will enable early detection of Alzheimer’s disease with an accurate, non-invasive, dynamic test, where the ongoing clearance of beta amyloid (Abeta) is measured. Abeta is considered to be the first hallmark of Alzheimer’s disease, and our test is the only blood test that measures the ongoing disease pathology demonstrated by Abeta clearance.